Pain and pain management in haemophilia

被引:64
作者
Auerswald, Guenter [1 ]
Dolan, Gerry [2 ]
Duffy, Anne [3 ]
Hermans, Cedric [4 ]
Jimenez-Yuste, Victor [5 ]
Ljung, Rolf [6 ,7 ]
Morfini, Massimo [8 ]
Lambert, Thierry [9 ,10 ]
Salek, Silva Zupancic [11 ,12 ]
机构
[1] Prof Hess Childrens Hosp, Klinikum Bremen Mitte, Bremen, Germany
[2] Queens Med Ctr, Dept Haematol, Nottingham, England
[3] Irish Haemophilia Soc, Dublin, Ireland
[4] Clin St Luc, Div Haematol, Brussels, Belgium
[5] Univ Autonoma Madrid, Hosp Univ La Paz, Unidad Coagulopatias, Serv Hematol, Madrid, Spain
[6] Lund Univ, Dept Paediat, Malmo, Sweden
[7] Skane Univ Hosp, Malmo Ctr Thrombosis & Haemostasis, Malmo, Sweden
[8] Azienda Osped Univ Careggi, Agcy Hemophilia & Reference Ctr Inherited Bleedin, Dept Emergency & Recept, Florence, Italy
[9] Bicetre AP HP Hosp, Hemophilia Care Ctr, Paris, France
[10] Fac Med Paris Sud, Paris, France
[11] Univ Hosp Ctr Zagreb, Natl Haemophilia Ctr, Rebro, Croatia
[12] Univ Osijek, Sch Med, Zagreb, Croatia
关键词
acute pain; bleed; chronic pain; haemophilia; pain management; quality of life; ACTIVATED FACTOR-VII; ORTHOPEDIC STATUS; HOME TREATMENT; INHIBITORS; REHABILITATION; EXPERIENCE; EPISODES; QUALITY; LIFE;
D O I
10.1097/MBC.0000000000000571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Joint pain is common in haemophilia and may be acute or chronic. Effective pain management in haemophilia is essential to reduce the burden that pain imposes on patients. However, the choice of appropriate pain-relieving measures is challenging, as there is a complex interplay of factors affecting pain perception. This can manifest as differences in patients' experiences and response to pain, which require an individualized approach to pain management. Prophylaxis with factor replacement reduces the likelihood of bleeds and bleed-related pain, whereas on-demand therapy ensures rapid bleed resolution and pain relief. Although use of replacement or bypassing therapy is often the first intervention for pain, additional pain relief strategies may be required. There is an array of analgesic options, but consideration should be paid to the adverse effects of each class. Nevertheless, a combination of medications that act at different points in the pain pathway may be beneficial. Nonpharmacological measures may also help patients and include active coping strategies; rest, ice, compression, and elevation; complementary therapies; and physiotherapy. Joint aspiration may also reduce acute joint pain, and joint steroid injections may alleviate chronic pain. In the longer term, increasing use of prophylaxis or performing surgery may be necessary to reduce the burden of pain caused by the degenerative effects of repeated bleeds. Whichever treatment option is chosen, it is important to monitor pain and adjust patient management accordingly. Beyond specific pain management approaches, ongoing collaboration between multidisciplinary teams, which should include physiotherapists and pain specialists, may improve outcomes for patients.
引用
收藏
页码:845 / 854
页数:10
相关论文
共 42 条
[31]   Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors [J].
Salaj, P. ;
Ovesna, P. ;
Penka, M. ;
Hedner, U. .
HAEMOPHILIA, 2012, 18 (06) :e409-e411
[32]   Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic [J].
Salaj, P. ;
Brabec, P. ;
Penka, M. ;
Pohlreichova, V. ;
Smejkal, P. ;
Cetkovsky, P. ;
Dusek, L. ;
Hedner, U. .
HAEMOPHILIA, 2009, 15 (03) :752-759
[33]   Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention [J].
Santagostino, E ;
Gringeri, A ;
Mannucci, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) :22-26
[34]   Guidelines for the management of hemophilia [J].
Srivastava, A. ;
Brewer, A. K. ;
Mauser-Bunschoten, E. P. ;
Key, N. S. ;
Kitchen, S. ;
Llinas, A. ;
Ludlam, C. A. ;
Mahlangu, J. N. ;
Mulder, K. ;
Poon, M. C. ;
Street, A. .
HAEMOPHILIA, 2013, 19 (01) :E1-E47
[35]   Epidemiological survey of haemophiliacs with inhibitors in France: orthopaedic status, quality of life and cost - the 'Statut Orthopedique des Patients Hemophiles' avec Inhibiteur study [J].
Stieltjes, Natalie ;
Torchet, Marie F. ;
Misrahi, Laure ;
Roussel-Robert, Valrie ;
Lambert, Thierry ;
Guerois, Claude ;
Bertrand, Marie A. ;
Briquel, Marie E. ;
Borel-Derlon, Annie ;
Dirat, Gerard .
BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (01) :4-11
[36]   Assessment of pain threshold in haemophilic patients [J].
Teyssler, P. ;
Kolostova, K. ;
Bobek, V. .
HAEMOPHILIA, 2014, 20 (02) :207-211
[37]   Pain and functional limitations in patients with severe haemophilia [J].
van Genderen, FR ;
Fischer, K ;
Heijnen, L ;
de Kleijn, P ;
van den Berg, HM ;
Helders, PJM ;
van Meeteren, NLU .
HAEMOPHILIA, 2006, 12 (02) :147-153
[38]   Pain status of patients with severe haemophilic arthropathy [J].
Wallny, T ;
Hess, L ;
Seuser, A ;
Zander, D ;
Brackmann, HH ;
Kraft, CN .
HAEMOPHILIA, 2001, 7 (05) :453-458
[39]   Assessment of acute and persistent pain management in patients with haemophilia [J].
Witkop, M. ;
Lambing, A. ;
Kachalsky, E. ;
Divine, G. ;
Rushlow, D. ;
Dinnen, J. .
HAEMOPHILIA, 2011, 17 (04) :612-619
[40]  
World Federation of Hemophilia, 2000, HEMOPHILIA FDN AUSTR, V22, P2